Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.

Source:http://linkedlifedata.com/resource/pubmed/id/18645005

Download in:

View as

General Info

PMID
18645005